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Editors: Anton N. Sidawy and Bruce A. PerlerFamilial abdominal aortic aneurysm is associated with
more complications after endovascular aneurysm repair
Koen M. van de Luijtgaarden, Frederico Bastos Gonçalves,
Sanne E. Hoeks, Danielle Majoor-Krakauer, Ellen V. Rouwet,
Robert J. Stolker, Hence J.M. Verhagen
Objective: A familial predisposition to abdominal aortic an-
eurysms (AAAs) is present in approximately one-ﬁfth of patients.
Nevertheless, the clinical implications of a positive family history
are not known. We investigated the risk of aneurysm-related
complications after endovascular aneurysm repair (EVAR) for
patients with and without a positive family history of AAA.
Methods: Patients treated with EVAR for intact AAAs in
the Erasmus University Medical Center between 2000 and
2012 were included in the study. Family history was
obtained by written questionnaire. Familial AAA (fAAA) was
deﬁned as patients having at least one ﬁrst-degree relative
affected with aortic aneurysm. The remaining patients were
considered sporadic AAA. Cardiovascular risk factors,
aneurysm morphology (aneurysm neck, aneurysm sac, and
iliac measurements), and follow-up were obtained pro-
spectively. The primary end point was complications after
EVAR, a composite of endoleaks, need for secondary in-
terventions, aneurysm sac growth, acute limb ischemia, and
postimplantation rupture. Secondary end points were spe-
ciﬁc components of the primary end point (presence of
endoleak, need for secondary intervention, and aneurysm
sac growth), aneurysm neck growth, and overall survival.
Kaplan-Meier estimates for the primary end point were
calculated and compared using log-rank (Mantel-Cox) test
of equality. A Cox-regression model was used to calculate
the independent risk of complications associated with fAAA.
Results: A total of 255 patients were included in the
study (88.6% men; age 72  7 years, median follow-up
3.3 years; interquartile range, 2.2-6.1). A total of 51 patients
(20.0%) were classiﬁed as fAAA. Patients with fAAA were
younger (69 vs 72 years; P = .015) and were less likely to
have ever smoked (58.8% vs 73.5%; P = .039). Preoperative
aneurysm morphology was similar in both groups. Patients
with fAAA had signiﬁcantly more complications after EVAR
(35.3% vs 19.1%; P = .013), with a twofold increased risk
(adjusted hazard ratio, 2.1; 95% conﬁdence interval, 1.2-
3.7). Secondary interventions (39.2% vs 20.1%; P = .004)
and aneurysm sac growth (20.8% vs 9.5%; P = .030) were
the most important elements accounting for the difference.
Furthermore, a trend toward more type I endoleaks during*Full articles available online at www.jvascsurg.org
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http://dx.doi.org/10.1016/S1078-5884(13)00779-Xfollow-up was observed (15.6% vs 7.4%; P = .063) and no
difference in overall survival.
Conclusions: The current study shows that patients with
a familial form of AAA develop more aneurysm-related
complications after EVAR, despite similar AAA morphology
at baseline. These ﬁndings suggest that patients with fAAA
form a speciﬁc subpopulation and create awareness for
a possible increase in the risk of complications after EVAR.The ﬁnancial implications of endovascular aneurysm repair
in the cost containment era
David H. Stone, Alexander J. Horvath, Philip P. Goodney, Eva
M. Rzucidlo, Brian W. Nolan, Daniel B. Walsh, Robert M.
Zwolak, Richard J. Powell
Objective: Endovascular aneurysm repair (EVAR) is
associated with signiﬁcant direct device costs. Such costs
place EVAR at odds with efforts to constrain healthcare
expenditures. This study examines the procedure-associated
costs and operating margins associated with EVAR at a ter-
tiary care academic medical center.
Methods: All infrarenal EVARs performed from April 2011
to March 2012 were identiﬁed (n = 127). Among this cohort,
49 patients met standard commercial instruction for use
guidelines, were treated using a single manufacturer device,
and billed to Medicare diagnosis-related group (DRG) 238. Of
these 49 patients, net technical operating margins (technical
revenue minus technical cost) were calculated in conjunction
with the hospital ﬁnance department. EVAR implant costs
were determined for each procedure. DRG 238-associated
costs and length of stay were benchmarked against other
academic medical centers using University Health System
Consortium 2012 data.
Results: Among the studied EVAR cohort (age 75, 82%
male, mean length of stay, 1.7 days), mean technical costs
totaled $31,672. Graft implants accounted for 52% of the
allocated technical costs. Institutional overhead was 17%
($5495) of total technical costs. Net mean total technical
EVAR-associated operating margins were â $4015 per pro-
cedure. Our institutional costs and length of stay, when
benchmarked against comparable centers, remained in the
lowest quartile nationally using University Health System
Consortium costs for DRG 238. Stent graft price did not
correlate with total EVAR market share.
Conclusions: EVAR is currently associated with signiﬁcant
negative operating margins among Medicare beneﬁciaries.
Currently, device costs account for over 50% of EVAR-asso-
ciated technical costs and did not impact EVAR market share,
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geons. These data indicate that EVAR must undergo dramatic
care delivery redesign for this practice to remain sustainable.Late open conversion after failed endovascular aortic
aneurysm repair
Chris Klonaris, Stella Lioudaki, Athanasios Katsargyris,
Emmanouil Psathas, George Kouvelos, Mikes Doulaptsis,
Chris Verikokos, Gregory Kouraklis
Objective: Endovascular aortic aneurysm repair (EVAR) is
widely used for the treatment of abdominal aortic aneu-
rysms. Complications secondary to EVAR are also treated
with endovascular techniques. When this is not applicable,
open surgical repair is mandatory. This study aims to present
our experience in open surgical repair after failed EVAR.
Methods: Within the period from 2004 through 2013, 18
patients (17 men; mean age, 73.9 years) were operated on
because of EVAR failure due to persistent type II endoleak
(n = 10), type I or III endoleak (n = 3), mixed-type endoleaks
(n = 2), stent graft thrombosis (n = 2), and aortoenteric
ﬁstulae (n = 1). Stent grafts used for EVAR were Zenith (n =
8), Talent (n = 4), Excluder (n = 4), and Anaconda (n = 2).
Results: Mean time interval between EVAR and open
conversion was 36 months (range, 2-120 months). Fifteen
(83.3%) operations were elective, and three (16.7%) were
urgent due to aneurysm rupture (n = 2) and aortoenteric
ﬁstula (n = 1). Six (33.3%) patients with type II endoleak were
treated with simple ligation of the culprit vessels, without
aortic clamping and stent graft explantation. In six (33.3%)
patients, the stent graft was partially removed except from
the segment attached to the proximal neck, while in ﬁve
(27.8%) patients, complete removal of the stent graft was
necessary. Finally, in one patient, with type III endoleak,
a hybrid endovascular and open repair was performed.
Clamping of the aorta was necessary in 12 (66.7%) patients
(infrarenal, n = 10 or suprarenal, n = 2). Overall operative
mortality was 5.6%. Postoperative complications included
one abdominal wall defect requiring surgical revision and
paroxysmal atrial ﬁbrillation both in the same patient, and
one case of pulmonary infection, requiring prolonged intu-
bation and intensive care unit stay for 6 days.
Conclusions: Late open conversion after failed EVAR re-
mains challenging. Avoidance of aortic cross-clamping and if
possible, partial or total preservation of the stent graft may
improve outcomes in terms of operative mortality and mor-
bidity. Elective operations seem to be associated with better
outcomes, prompting thus for close follow-up of EVAR patients
and early decision for conversion if other options are doubtful.Functional status of elderly adults before and after
interventions for critical limb ischemia
Todd R. Vogel, Gregory F. Petroski, Robin L. Kruse
Objective: The impact of interventions for critical limb
ischemia (CLI) on functional status in the elderly remainsunclear. Open and endovascular procedures were
evaluated.
Methods: Medicare inpatient claims were linked with
nursing home assessment data to identify elective admis-
sions for lower extremity procedures for CLI. A functional
impairment score (0-28; higher scores indicating greater
impairment) based on residents' need for assistance with
self-care activities, walking, and locomotion was calculated
before and after interventions. Hierarchical modeling
determined the effect of the surgery on residents' function,
controlling for comorbidity, cognition, and prehospital
function.
Results: Three hundred ﬁfty-two and 350 patients un-
derwent open and endovascular procedures, respectively
(rest pain, 84; ulceration, 351; gangrene, 267). Hospitaliza-
tion was associated with a signiﬁcant worsening in function
following both procedures. Disease severity was associated
with the amount of initial decline but not with the rate of
recovery (P > .35). Residents who received open surgery
improved more quickly following hospital discharge (P =
.011).
Conclusions: In the frail elderly, open and endovascular
procedures for CLI were associated with similar initial de-
clines in functional status, suggesting that compared with
open procedures, less invasive endovascular procedures
were not associated with maintaining baseline function. In
this select population, endovascular procedures for CLI
were not associated with improved functional status over
time compared with open. Six months posthospital, pa-
tients who received traditional open bypass had sig-
niﬁcantly better functional status than those who received
endovascular procedures for all CLI diagnoses. Further
analysis is required to assist stakeholders in performing
procedures most likely to preserve functional status in the
frail elderly and nursing home population.Primary stenting of femoropopliteal atherosclerotic lesions
using new helical interwoven nitinol stents
Yiu Che Chan, Stephen W. Cheng, Albert C. Ting, Grace C.
Cheung
Background: The Supera helical interwoven nitinol stent
has enhanced ﬂexibility in counteracting fractures when
placed in the femoropopliteal arteries and may improve
patency. The aim of this study is to assess the early results
of the Supera stent in symptomatic patients with femo-
ropopliteal atherosclerotic lesions.
Methods: From October 2011 to April 2013, patients
with symptomatic femoropopliteal lesions were treated
with angioplasty and primary stenting using the Supera
stent. They were followed up at 1, 3, 6, and 12 months with
clinical, duplex, and radiographic assessments. Failure was
deﬁned as >50% restenosis of the target lesion on duplex
ultrasound imaging or stent fracture on X rays.
Results: A total of 78 consecutive patients (46 males, 32
females) with 82 legs, mean age of 78.5 years (range, 57-97)
were included. Symptoms of claudication, rest pain, and
European Journal of Vascular and Endovascular Surgery Volume 47 Issue 2 p. 211e214 February/2014 213tissue loss were 48 (59%), 8 (10.1%), and 30 (37%),
respectively. Ninety-six Supera stents were inserted in total.
In 44 (53.7%) of the legs, stents were extended to the
popliteal segments. The mean stented length was 12.6 cm
(range, 4.0-38.0 cm). The primary patency rates at 6 and
12 months were 83.5% and 78.6%, respectively. The ankle
brachial index increased from 0.58  0.16 preoperative to
0.87  0.14 postoperative. There were no stent fractures.
Patency rate was not affected by severity of symptoms,
stent lengths, femoro/popliteal stents (log-rank test: P = .50,
.13, .52). All the patients reported symptomatic improve-
ment. There was no procedural- or device-related morbidity
or mortality, no major amputation after revascularization,
10 patients died of unrelated cardiopulmonary/renal causes
on follow-up.
Conclusions: Our early experience shows that the Supera
stents are effective in our cohort of elderly patients, with
acceptable patency rates. There were no stent fractures so
far even with stenting of the popliteal segments.Endovascular-ﬁrst approach is not associated with worse
amputation-free survival in appropriately selected
patients with critical limb ischemia
Karan Garg, Patrick A. Kaszubski, Rameen Moridzadeh,
Caron B. Rockman, Mark A. Adelman, Thomas S. Maldo-
nado, Frank J. Veith, Firas F. Mussa
Objective: Endovascular interventions for critical limb
ischemia are associated with inferior limb salvage (LS) rates
in most randomized trials and large series. This study
examined the long-term outcomes of selective use of
endovascular-ﬁrst (endo-ﬁrst) and open-ﬁrst strategies in
302 patients from March 2007 to December 2010.
Methods: Endo-ﬁrst was selected if (1) the patient had
short (5-cm to 7-cm occlusions or stenoses in crural ves-
sels); (2) the disease in the superﬁcial femoral artery was
limited to TransAtlantic Inter-Society Consensus II A, B, or C;
and (3) no impending limb loss. Endo-ﬁrst was performed in
187 (62%), open-ﬁrst in 105 (35%), and 10 (3%) had hybrid
procedures.
Results: The endo-ﬁrst group was older, with more dia-
betes and tissue loss. Bypass was used more to infrapopli-
teal targets (70% vs 50%, P = .031). The 5-year mortality was
similar (open, 48%; endo, 42%; P = .107). Secondary pro-
cedures (endo or open) were more common after open-ﬁrst
(open, 71 of 105 [68%] vs endo, 102 of 187 [55%]; P = .029).
Compared with open-ﬁrst, the 5-year LS rate for endo-ﬁrst
was 85% vs 83% (P = .586), and amputation-free survival
(AFS) was 45% vs 50% (P = .785). Predictors of death were
age >75 years (hazard ratio [HR], 3.3; 95% conﬁdence in-
terval [CI], 1.7-6.6; P = .0007), end-stage renal disease
(ESRD) (HR, 3.4; 95% CI, 2.1-5.6; P < .0001), and prior stroke
(HR, 1.6; 95% CI, 1.03-2.3; P = .036). Predictors of limb loss
were ESRD (HR, 2.5; 95% CI, 1.2-5.4; P = .015) and below-
the-knee intervention (P = .041). Predictors of worse AFS
were older age (HR, 2.03; 95% CI, 1.13-3.7; P = .018), ESRD(HR, 3.2; 95% CI, 2.1-5.11; P < .0001), prior stroke (P =
.0054), and gangrene (P = .024).
Conclusions: At 5 years, endo-ﬁrst and open-ﬁrst revas-
cularization strategies had equivalent LS rates and AFS in
patients with critical limb ischemia when properly selected.
A patient-centered approach with close surveillance im-
proves long-term outcomes for both open and endo
approaches.Managing iliofemoral deep venous thrombosis of
pregnancy with a strategy of thrombus removal is safe and
avoids post-thrombotic morbidity
Santiago Herrera, Anthony J. Comerota, Subhash Thakur,
Shiraz Sunderji, Robert DiSalle, Sahira N. Kazanjian, Zakaria
Assi
Background: Extensive deep venous thrombosis (DVT)
during pregnancy is usually treated with anticoagulation
alone, risking signiﬁcant post-thrombotic syndrome (PTS) in
young patients. Catheter-directed thrombolysis (CDT) and
operative venous thrombectomy have been safely and
effectively used in nonpregnant patients, demonstrating
signiﬁcant reduction in post-thrombotic morbidity. This
report reviews short- and long-term outcomes of 13 pa-
tients with extensive DVT of pregnancy treated with
a strategy of thrombus removal.
Methods: From 1999 to 2013, 13 patients with iliofe-
moral DVT during pregnancy were offered CDT, pharma-
comechanical thrombolysis (PMT), and/or venous
thrombectomy. Gestational age ranged from 8 to
34 weeks. Fetal monitoring was performed throughout
hospitalization. Radiation exposure was minimized with
pelvic lead shields, focal ﬂuoroscopy, and limited angio-
graphic runs. Follow-up included objective vein evaluation
using venous duplex and PTS assessment using the Villalta
scale.
Results: CDT and/or PMT were used in 11 patients. Two
patients underwent venous thrombectomy alone, and one
patient had operative thrombectomy as an adjunct to CDT
and PMT. Each patient had complete or near-complete
thrombus resolution and rapid improvement in clinical
symptoms. Eight of 11 having CDT or PMT underwent
venoplasty and stenting of the involved iliac veins. Twelve of
the 13 delivered healthy infants at term. One patient opted
for termination of her pregnancy. Mean patient and ges-
tational ages were 26 years and 26 weeks, respectively.
Mean follow-up was 1.3 years, with only one recurrence.
Duplex ultrasonography demonstrated patent veins in all
but one patient and normal valve function in 10 patients.
Eleven patients had Villalta scores <5 (considered normal),
with a mean score of 0.7.
Conclusions: Extensive DVT of pregnancy can be effec-
tively and safely treated with a strategy of thrombus
removal, resulting in a patent venous system, normal valve
function in many, prevention of PTS, and reduction in
recurrence.
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Prateek K. Gupta, Sara Fernandes-Taylor, Bala Ramanan,
Travis L. Engelbert, K. Craig Kent
Objective: Existing literature on readmission after vas-
cular surgery is limited. The upcoming reduction in Medi-
care reimbursement for institutions with high readmission
rates mandates an accurate understanding of this issue. In
this study, we characterize the frequency and causes of 30-
day unplanned readmissions after elective vascular surgery.
Methods: Patients who underwent elective carotid
endarterectomy (CEA), endovascular aortic repair (EVAR),
open abdominal aortic aneurysm (oAAA) repair, or infrain-
guinal bypass grafting (BPG) were identiﬁed from the
American College of Surgeons (ACS) National Surgical
Quality Improvement Program (NSQIP) 2011 database (n =
11,246). Multivariable logistic regression was used to
determine variables that contributed to 30-day unplanned
readmissions for each surgery type.Results: The unadjusted unplanned readmission rates
after the four vascular procedures ranged from 6.5% for
CEA to 15.7% for BPG. In multivariable analyses, patient
comorbidities were associated with unplanned readmission
after BPG and CEA (P < .05), whereas postoperative com-
plications were more consistently associated with un-
planned readmission after EVAR and oAAA repair (P < .05).
For all procedures, complications leading to readmission
developed more frequently after discharge. Thirty-day
mortality was signiﬁcantly higher in readmitted patients
after BPG (1.9% vs 0.3%), EVAR (3.9% vs 0.1%), and CEA
(2.2% vs 0.2%; P < .001 for each), but not after oAAA repair.
Conclusions: Select comorbidities and postoperative
complications contribute to unplanned readmissions after
vascular surgery. The characteristics of readmitted patients
vary with the type of procedure. Interventions designed to
mitigate these factors have the potential to reduce un-
planned readmissions but likely need to vary with the type
of vascular treatment.
